152 related articles for article (PubMed ID: 35695317)
41. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
[TBL] [Abstract][Full Text] [Related]
42. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants.
Mahajan S; Agarwal S; Kocheri N; Jain D; Mathur SR; Iyer VK
Cytopathology; 2018 Jun; 29(3):233-240. PubMed ID: 29638022
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
Hirokawa M; Higuchi M; Suzuki A; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2020 Oct; 67(10):1071-1075. PubMed ID: 32595200
[TBL] [Abstract][Full Text] [Related]
44. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
45. Better understanding in the differentiation of thyroid follicular adenoma, follicular carcinoma, and follicular variant of papillary carcinoma: a retrospective study.
Yoon JH; Kim EK; Youk JH; Moon HJ; Kwak JY
Int J Endocrinol; 2014; 2014():321595. PubMed ID: 25309594
[TBL] [Abstract][Full Text] [Related]
46. Clinical utility of KAP-1 expression in thyroid lesions.
Martins MB; Marcello MA; Morari EC; Cunha LL; Soares FA; Vassallo J; Ward LS
Endocr Pathol; 2013 Jun; 24(2):77-82. PubMed ID: 23645532
[TBL] [Abstract][Full Text] [Related]
47. Modified Transverse-Vertical Gross Examination: a Better Method for the Detection of Definite Capsular Invasion in Encapsulated Follicular-Patterned Thyroid Neoplasms.
Oh HS; Kim SJ; Song E; Lee YM; Sung TY; Kim WG; Kim TY; Song DE
Endocr Pathol; 2019 Jun; 30(2):106-112. PubMed ID: 30661168
[TBL] [Abstract][Full Text] [Related]
48. Ultrasound predictors of malignancy in indeterminate thyroid nodules.
Matthey-Gie ML; Walsh SM; O'Neill AC; Lowery A; Evoy D; Gibbons D; Prichard RS; Skehan S; McDermott EW
Ir J Med Sci; 2014 Dec; 183(4):633-7. PubMed ID: 24402165
[TBL] [Abstract][Full Text] [Related]
49. The demise of follicular carcinoma of the thyroid gland.
LiVolsi VA; Asa SL
Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
[TBL] [Abstract][Full Text] [Related]
50. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management.
Logani S; Gupta PK; LiVolsi VA; Mandel S; Baloch ZW
Diagn Cytopathol; 2000 Dec; 23(6):380-5. PubMed ID: 11074641
[TBL] [Abstract][Full Text] [Related]
51. Ultrasonographic and cytologic assessments of follicular neoplasms of the thyroid: Predictive features differentiating follicular carcinoma from follicular adenoma.
Ahn HS; Kim HS; Hong MJ
PLoS One; 2022; 17(7):e0271437. PubMed ID: 35862471
[TBL] [Abstract][Full Text] [Related]
52. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
[TBL] [Abstract][Full Text] [Related]
53. Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.
Saiegh L; Shechner C; Dickstein G; Sheikh-Ahmad M; Reut M; Odeh M; Toubi A; Bejar J
Minerva Endocrinol; 2014 Mar; 39(1):43-52. PubMed ID: 24513603
[TBL] [Abstract][Full Text] [Related]
54. UTILITY OF AFIRMA GENE EXPRESSION CLASSIFIER FOR EVALUATION OF INDETERMINATE THYROID NODULES AND CORRELATION WITH ULTRASOUND RISK ASSESSMENT: SINGLE INSTITUTIONAL EXPERIENCE.
Sultan R; Levy S; Sulanc E; Honasoge M; Rao SD
Endocr Pract; 2020 May; 26(5):543-551. PubMed ID: 31968199
[No Abstract] [Full Text] [Related]
55. Clinicopathologic Characteristics of Thyroid Nodules Positive for the
Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE
Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086
[No Abstract] [Full Text] [Related]
56. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
Saleh HA; Jin B; Barnwell J; Alzohaili O
Diagn Pathol; 2010 Jan; 5():9. PubMed ID: 20181018
[TBL] [Abstract][Full Text] [Related]
57. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
58. Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules.
Jabiev AA; Ikeda MH; Reis IM; Solorzano CC; Lew JI
Ann Surg Oncol; 2009 Nov; 16(11):3140-5. PubMed ID: 19655201
[TBL] [Abstract][Full Text] [Related]
59. Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid.
Manivannan P; Siddaraju N; Jatiya L; Verma SK
Indian J Biochem Biophys; 2012 Oct; 49(5):392-4. PubMed ID: 23259327
[TBL] [Abstract][Full Text] [Related]
60. Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm.
Lee SH; Baek JS; Lee JY; Lim JA; Cho SY; Lee TH; Ku YH; Kim HI; Kim MJ
Endocr Pathol; 2013 Dec; 24(4):177-83. PubMed ID: 24014040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
